Covering Noninvasive Prenatal Screening
Autor: | Arnold Cohen |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Pregnancy medicine.medical_specialty medicine.diagnostic_test business.industry Obstetrics Health Policy MEDLINE Prenatal diagnosis medicine.disease Article 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Prenatal screening Prenatal Diagnosis 030220 oncology & carcinogenesis Humans Medicine Female Genetic Testing business Genetic testing |
Zdroj: | Health Affairs. 37:1533-1533 |
ISSN: | 1544-5208 0278-2715 |
DOI: | 10.1377/hlthaff.2018.0959 |
Popis: | Genetic testing and spending on that testing have grown rapidly since the mapping of the human genome in 2003. However, it is not widely known how many tests there are, how they are used, and how they are paid for. Little evidence from large data sets about their use has emerged. We shed light on the issue of genetic testing by providing an overview of the testing landscape. We examined test availability and spending for the full spectrum of genetic tests, using unique data sources on test availability and commercial payer spending for privately insured populations, focusing particularly on tests measuring multiple genes in the period 2014–17. We found that there were approximately 75,000 genetic tests on the market, with about ten new tests entering the market daily. Prenatal tests accounted for the highest percentage of spending on genetic tests, and spending on hereditary cancer tests accounted for the second-highest. Our results provide insights for those interested in assessing genetic testing markets, test usage, and health policy implications, including current debates over the most appropriate regulatory and payer coverage mechanisms. |
Databáze: | OpenAIRE |
Externí odkaz: |